These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10037513)

  • 1. Post-sclerotherapy compression: controlled comparative study of duration of compression and its effects on clinical outcome.
    Weiss RA; Sadick NS; Goldman MP; Weiss MA
    Dermatol Surg; 1999 Feb; 25(2):105-8. PubMed ID: 10037513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to utilize compression after sclerotherapy.
    Goldman MP
    Dermatol Surg; 2002 Sep; 28(9):860-2. PubMed ID: 12269885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of short-term compression after sclerotherapy for telangiectatic varicose veins.
    Bayer A; Kuznik N; Langan EA; Recke A; Recke AL; Faerber G; Kaschwich M; Kleemann M; Kahle B
    J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):435-443. PubMed ID: 32502730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous hyperpigmentation following venous sclerotherapy treated with deferoxamine mesylate.
    Lopez L; Dilley RB; Henriquez JA
    Dermatol Surg; 2001 Sep; 27(9):795-8. PubMed ID: 11553167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of pain associated with varicose and telangiectatic leg veins after compression sclerotherapy.
    Weiss RA; Weiss MA
    J Dermatol Surg Oncol; 1990 Apr; 16(4):333-6. PubMed ID: 2324369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing hyperpigmentation after sclerotherapy: A randomized clinical trial.
    Gonzalez Ochoa AJ; Carrillo J; Manríquez D; Manrique F; Vazquez AN
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):154-162. PubMed ID: 32739509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cryocompression sclerotherapy of reticular veins and teleangiectasias].
    Bogachev VI; Kuznetsov MR; Lobanov VN; Turkin PI
    Angiol Sosud Khir; 2018; 24(3):92-97. PubMed ID: 30321152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Local drugs in treating and decreasing the incidence of adverse reactions after sclerotherapy of telangiectasia].
    Bogachev VI; Boldin BV; Turkin PI; Lobanov VN
    Angiol Sosud Khir; 2019; 25(4):102-107. PubMed ID: 31855206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of graduated compression stockings for an additional 3 weeks after sclerotherapy treatment of reticular and telangiectatic leg veins.
    Nootheti PK; Cadag KM; Magpantay A; Goldman MP
    Dermatol Surg; 2009 Jan; 35(1):53-7; discussion 57-8. PubMed ID: 19067733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compression after sclerotherapy for telangiectasias and reticular leg veins: a randomized controlled study.
    Kern P; Ramelet AA; Wütschert R; Hayoz D
    J Vasc Surg; 2007 Jun; 45(6):1212-6. PubMed ID: 17467226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injection sclerotherapy for varicose veins.
    Tisi PV; Beverley CA
    Cochrane Database Syst Rev; 2002; (1):CD001732. PubMed ID: 11869605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerotherapy in tumescent anesthesia of reticular veins and telangiectasias.
    Ramelet AA
    Dermatol Surg; 2012 May; 38(5):748-51. PubMed ID: 22268802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. My sclerotherapy technique for telangiectasia and reticular veins.
    Goldman MP
    Dermatol Surg; 2010 Jun; 36 Suppl 2():1040-5. PubMed ID: 20590711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compression versus sclerotherapy for patients with isolated refluxing reticular veins and telangiectasia: a randomized trial comparing quality-of-life outcomes.
    Schul MW; Eaton T; Erdman B
    Phlebology; 2011 Jun; 26(4):148-56. PubMed ID: 21422193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open-label trial.
    Parlar B; Blazek C; Cazzaniga S; Naldi L; Kloetgen HW; Borradori L; Buettiker U
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):549-54. PubMed ID: 25069999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, randomized study comparing pure chromated glycerin with chromated glycerin with 1% lidocaine and epinephrine for sclerotherapy of telangiectasias and reticular veins.
    Kern P; Ramelet AA; Wutschert R; Mazzolai L
    Dermatol Surg; 2011 Nov; 37(11):1590-4. PubMed ID: 21883648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of reticular veins and telangiectases.
    Smith PC
    Phlebology; 2015 Nov; 30(2 Suppl):46-52. PubMed ID: 26556703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized clinical trial of different bandage regimens after foam sclerotherapy for varicose veins.
    O'Hare JL; Stephens J; Parkin D; Earnshaw JJ
    Br J Surg; 2010 May; 97(5):650-6. PubMed ID: 20306530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Telangiectasias associated with reticular veins. Sclerotherapy or combined sclerotherapeutic and surgical approach?].
    Albanese V; Cavallaro G
    Minerva Cardioangiol; 2002 Feb; 50(1):29-37. PubMed ID: 11830716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus for sclerotherapy.
    Weiss MA; Hsu JT; Neuhaus I; Sadick NS; Duffy DM
    Dermatol Surg; 2014 Dec; 40(12):1309-18. PubMed ID: 25418805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.